Investor
Rejuveron Life Sciences
Baar · Switzerland
Centenara Labs (formerly Rejuveron) invests in and develops therapies targeting geriatric diseases to expand healthspan and longevity.
Stage
Series B
Sectors
Deep Tech
Cheque
Not confirmed
Invests in
2 countries
Sectors
Invests in
About
Centenara Labs develops and invests in therapies that target geriatric diseases. The organisation is focused on transforming the most promising discoveries in aging research into therapies that extend good health years. It builds a broad pipeline of new therapies via founding or investing in early-staged therapeutics companies. The firm focuses on breakthrough therapeutics that target the hallmarks of aging.
How to approach
Contact the firm via the general enquiry form or email to initiate a partnership conversation.
Portfolio · 1 · tap a company to read about it